In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...
Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
The dual-mechanism drug targets ULBP6, which is secreted by tumor cells and ... while 23ME-01473 slowed the growth of ...
In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed ... T-cell acute ...
New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with ...
Research continues on lung cancer, as rates of cancer rise among younger patients and women, UVA Cancer Center researchers ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback